Solicitation of Nominations for Membership To Serve on the Advisory Committee on Infant Mortality, 4329-4330 [2020-01129]
Download as PDF
<![CDATA[
4329
Federal Register / Vol. 85, No. 16 / Friday, January 24, 2020 / Notices
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
NHSC Loan Repayment Programs—Participant Survey ....
NHSC Loan Repayment Programs—Site Survey ...............
Grantee Programs—Trainee Survey ...................................
Grantee Programs—Alumni Survey ....................................
Grantee Programs—Site Survey .........................................
Grantee Programs—Grantee Organization Survey .............
8,000
18,000
8,000
2,000
5,000
300
1
1
1
1
1
1
8,000
18,000
8,000
2,000
5,000
300
0.33
0.33
0.33
0.16
0.33
0.33
2,640
5,940
2,640
320
1,650
99
Total ..............................................................................
41,300
........................
41,300
........................
13,289
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions; (2) the accuracy of the
estimated burden; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020–01119 Filed 1–23–20; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Solicitation of Nominations for
Membership To Serve on the Advisory
Committee on Infant Mortality
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
AGENCY:
ACTION:
Request for nominations.
HRSA is seeking nominations
of qualified candidates for consideration
for appointment as members of the
Advisory Committee on Infant Mortality
(ACIM). The ACIM provides advice to
the Secretary of HHS on Department
activities and programs directed at
reducing infant mortality and improving
the health status of pregnant women
and infants. With a focus on life course,
ACIM addresses disparities in maternal
health to improve maternal health
outcomes, including preventing and
reducing maternal mortality and severe
maternal morbidity. HRSA is seeking
SUMMARY:
lotter on DSKBCFDHB2PROD with NOTICES
Number of
responses per
respondent
VerDate Sep<11>2014
17:03 Jan 23, 2020
Jkt 250001
nominations of qualified candidates to
fill positions on the ACIM.
DATES: Written nominations for
membership on the ACIM must be
received on or before February 24, 2020.
ADDRESSES: Nomination packages must
be submitted electronically as email
attachments to David de la Cruz, the
ACIM’s Designated Federal Official, at:
dcruz@hrsa.gov.
FOR FURTHER INFORMATION CONTACT:
David de la Cruz, Ph.D., MPH. Address:
Maternal and Child Health Bureau,
HRSA 5600 Fishers Lane, Room 18N25,
Rockville, MD 20857; phone number:
301–443–0543; email: dcruz@hrsa.gov.
A copy of the ACIM charter and list of
the current membership can be obtained
by accessing the ACIM website at
https://www.hrsa.gov/advisorycommittees/Infant-Mortality/.
SUPPLEMENTARY INFORMATION: The ACIM
was established in 1991 and advises the
Secretary of HHS on Department
activities and programs directed at
reducing infant mortality and improving
the health status of pregnant women
and infants. The ACIM represents a
public-private partnership at the highest
level to provide guidance and focus
attention on the policies and resources
required to address the reduction of
infant mortality and the improvement of
the health status of pregnant women
and infants. Women who experience
conditions such as hypertension,
malnutrition, substance use disorder,
and/or diabetes during pregnancy are at
an elevated risk of delivering a baby
who is low birth weight or premature.
These are two of the leading causes of
infant mortality. The ACIM provides
advice on how best to coordinate a
myriad of federal, state, local, and
private programs and efforts that are
designed to deal with the health and
social problems affecting infant
mortality and maternal health including
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
implementation of the Healthy Start
program and the maternal and infant
health objectives from the National
Health Promotion and Disease
Prevention Objectives.
Nominations: HRSA is requesting
nominations for voting members to
serve as Special Government Employees
(SGEs) on the ACIM. The Secretary
appoints up to 21 members for a term
of up to 4 years. Nominees should
include medical, technical, or scientific
professionals with special expertise in
the field of maternal and child health,
in particular infant mortality and related
health disparities; members of the
public having special expertise about or
concern with infant mortality; and/or
representatives from such public health
constituencies, consumers, and medical
professional societies. Interested
applicants may self-nominate or be
nominated by another individual or
organization.
Members appointed as SGEs receive a
stipend and reimbursement for per diem
and travel expenses incurred for
attending the ACIM meetings and/or
conducting other business on behalf of
the ACIM, as authorized by 5 U.S.C.
5703 for persons employed
intermittently in government service.
The ACIM meets approximately twice
per year.
The following information must be
included in the package of materials
submitted for each individual being
nominated for consideration: (1) A
statement that includes the name and
affiliation of the nominee and a clear
statement regarding the basis for the
nomination, including the area(s) of
expertise that may qualify a nominee for
service on the ACIM, as described
above; (2) confirmation the nominee is
willing to serve as a member of the
ACIM; (3) the nominee’s contact
information (please include home
address, work address, daytime
E:\FR\FM\24JAN1.SGM
24JAN1
4330
Federal Register / Vol. 85, No. 16 / Friday, January 24, 2020 / Notices
telephone number, and an email
address); and (4) a current copy of the
nominee’s curriculum vitae.
Nomination packages may be submitted
directly by the individual being
nominated or by the person/
organization recommending the
candidate.
HHS endeavors to ensure that the
membership of the ACIM is fairly
balanced in terms of points of view
represented and that individuals from a
broad representation of geographic
areas, gender, and ethnic and minority
groups, as well as individuals with
disabilities, are considered for
membership. Appointments shall be
made without discrimination on the
basis of age, ethnicity, gender, sexual
orientation, or cultural, religious, or
socioeconomic status.
Individuals who are selected to be
considered for appointment will be
required to provide detailed information
regarding their financial holdings,
consultancies, and research grants or
contracts. Disclosure of this information
is necessary in order for HRSA ethics
officials to determine whether there is a
potential conflict of interest between the
SGE’s public duties as a member of the
ACIM and their private interests,
including an appearance of a loss of
impartiality as defined by federal laws
and regulations, and to identify any
required remedial action needed to
address the potential conflict.
Authority: The ACIM was established
under provisions of section 222 of the Public
Health Service Act (42 U.S.C. 217a), as
amended. The ACIM is governed by
provisions of the Federal Advisory
Committee Act (FACA), as amended (5 U.S.C.
App.), as well as 41 CFR part 102–3, which
set forth standards for the formation and use
of Advisory Committees.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020–01129 Filed 1–23–20; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
lotter on DSKBCFDHB2PROD with NOTICES
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
VerDate Sep<11>2014
17:03 Jan 23, 2020
Jkt 250001
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; PrEP for
HIV Prevention among Substance Using
Populations (R01 Clinical Trial Optional).
Date: February 12, 2020.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Trinh Tran, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Boulevard, MSC 9550, Bethesda, MD 20892,
trinh.tran@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; MultiSite Studies for System-Level
Implementation of Substance Use Prevention
and Treatment Services (R01; R34).
Date: February 19, 2020.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Yvonne Owens Ferguson,
Ph.D., Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH/DHHS, 6001 Executive
Blvd., Rm. 4234, Bethesda, MD 20892, 301–
402–7371, yvonne.ferguson@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis; Panel
Development of Medications to Prevent and
Treat Opioid Use Disorders and Overdose
(UG3/UH3 (Clinical Trials Optional).
Date: February 21, 2020.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Ivan K Navarro, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH/DHHS, 6001 Executive
Blvd., Rm. 4242, MSC 9550, Bethesda, MD
20892, 301–827–5833, ivan.navarro@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
PO 00000
Frm 00062
Fmt 4703
Sfmt 9990
Dated: January 17, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–01152 Filed 1–23–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, PAR–16–413: NIAID
Investigator Initiated Program Project.
Date: February 11, 2020.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Annie Walker-Abbey,
Ph.D., Scientific Review Officer, Scientific
Review Program, National Institute of Allergy
and Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E70A,
Rockville, MD 20852, 240–627–3390,
aabbey@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 17, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–01151 Filed 1–23–20; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\24JAN1.SGM
24JAN1
]]>Agencies
[Federal Register Volume 85, Number 16 (Friday, January 24, 2020)]
[Notices]
[Pages 4329-4330]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01129]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Solicitation of Nominations for Membership To Serve on the
Advisory Committee on Infant Mortality
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Request for nominations.
-----------------------------------------------------------------------
SUMMARY: HRSA is seeking nominations of qualified candidates for
consideration for appointment as members of the Advisory Committee on
Infant Mortality (ACIM). The ACIM provides advice to the Secretary of
HHS on Department activities and programs directed at reducing infant
mortality and improving the health status of pregnant women and
infants. With a focus on life course, ACIM addresses disparities in
maternal health to improve maternal health outcomes, including
preventing and reducing maternal mortality and severe maternal
morbidity. HRSA is seeking nominations of qualified candidates to fill
positions on the ACIM.
DATES: Written nominations for membership on the ACIM must be received
on or before February 24, 2020.
ADDRESSES: Nomination packages must be submitted electronically as
email attachments to David de la Cruz, the ACIM's Designated Federal
Official, at: [email protected].
FOR FURTHER INFORMATION CONTACT: David de la Cruz, Ph.D., MPH. Address:
Maternal and Child Health Bureau, HRSA 5600 Fishers Lane, Room 18N25,
Rockville, MD 20857; phone number: 301-443-0543; email: [email protected].
A copy of the ACIM charter and list of the current membership can be
obtained by accessing the ACIM website at https://www.hrsa.gov/advisory-committees/Infant-Mortality/.
SUPPLEMENTARY INFORMATION: The ACIM was established in 1991 and advises
the Secretary of HHS on Department activities and programs directed at
reducing infant mortality and improving the health status of pregnant
women and infants. The ACIM represents a public-private partnership at
the highest level to provide guidance and focus attention on the
policies and resources required to address the reduction of infant
mortality and the improvement of the health status of pregnant women
and infants. Women who experience conditions such as hypertension,
malnutrition, substance use disorder, and/or diabetes during pregnancy
are at an elevated risk of delivering a baby who is low birth weight or
premature. These are two of the leading causes of infant mortality. The
ACIM provides advice on how best to coordinate a myriad of federal,
state, local, and private programs and efforts that are designed to
deal with the health and social problems affecting infant mortality and
maternal health including implementation of the Healthy Start program
and the maternal and infant health objectives from the National Health
Promotion and Disease Prevention Objectives.
Nominations: HRSA is requesting nominations for voting members to
serve as Special Government Employees (SGEs) on the ACIM. The Secretary
appoints up to 21 members for a term of up to 4 years. Nominees should
include medical, technical, or scientific professionals with special
expertise in the field of maternal and child health, in particular
infant mortality and related health disparities; members of the public
having special expertise about or concern with infant mortality; and/or
representatives from such public health constituencies, consumers, and
medical professional societies. Interested applicants may self-nominate
or be nominated by another individual or organization.
Members appointed as SGEs receive a stipend and reimbursement for
per diem and travel expenses incurred for attending the ACIM meetings
and/or conducting other business on behalf of the ACIM, as authorized
by 5 U.S.C. 5703 for persons employed intermittently in government
service. The ACIM meets approximately twice per year.
The following information must be included in the package of
materials submitted for each individual being nominated for
consideration: (1) A statement that includes the name and affiliation
of the nominee and a clear statement regarding the basis for the
nomination, including the area(s) of expertise that may qualify a
nominee for service on the ACIM, as described above; (2) confirmation
the nominee is willing to serve as a member of the ACIM; (3) the
nominee's contact information (please include home address, work
address, daytime
[[Page 4330]]
telephone number, and an email address); and (4) a current copy of the
nominee's curriculum vitae. Nomination packages may be submitted
directly by the individual being nominated or by the person/
organization recommending the candidate.
HHS endeavors to ensure that the membership of the ACIM is fairly
balanced in terms of points of view represented and that individuals
from a broad representation of geographic areas, gender, and ethnic and
minority groups, as well as individuals with disabilities, are
considered for membership. Appointments shall be made without
discrimination on the basis of age, ethnicity, gender, sexual
orientation, or cultural, religious, or socioeconomic status.
Individuals who are selected to be considered for appointment will
be required to provide detailed information regarding their financial
holdings, consultancies, and research grants or contracts. Disclosure
of this information is necessary in order for HRSA ethics officials to
determine whether there is a potential conflict of interest between the
SGE's public duties as a member of the ACIM and their private
interests, including an appearance of a loss of impartiality as defined
by federal laws and regulations, and to identify any required remedial
action needed to address the potential conflict.
Authority: The ACIM was established under provisions of section
222 of the Public Health Service Act (42 U.S.C. 217a), as amended.
The ACIM is governed by provisions of the Federal Advisory Committee
Act (FACA), as amended (5 U.S.C. App.), as well as 41 CFR part 102-
3, which set forth standards for the formation and use of Advisory
Committees.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020-01129 Filed 1-23-20; 8:45 am]
BILLING CODE 4165-15-P
